Gross Profit (Annual) Chart

View Gross Profit (Annual) for AMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (Annual) Chart
Start Trial

Historical Gross Profit (Annual) Data

View and export this data back to 1998. Start Trial.
Date Value
December 31, 2025 118.12M
December 31, 2024 78.40M
December 31, 2023 202.59M
December 31, 2022 239.24M
December 31, 2021 458.95M
December 31, 2020 484.32M
December 31, 2019 334.26M
December 31, 2018 173.71M
December 31, 2017 136.90M
December 31, 2016 94.28M
December 31, 2015 52.97M
December 31, 2014 32.87M
December 31, 2013 13.57M
December 31, 2012 -0.4513M
Date Value
December 31, 2011 -0.1004M
December 31, 2010 -0.10M
December 31, 2009 -0.5818M
December 31, 2008 -0.2542M
December 31, 2007 0.00
December 31, 2006 0.00
December 31, 2005 0.00
December 31, 2004 -0.7525M
December 31, 2003 -0.564M
December 31, 2002 26.17M
December 31, 2001 11.54M
December 31, 2000 12.47M
December 31, 1999 5.929M
December 31, 1998 1.752M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (Annual) Range, Past 5 Years

View Gross Profit (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (Annual) Benchmarks

View Gross Profit (Annual) Benchmarks
Start Trial
Neurocrine Biosciences, Inc. 2.808B
DBV Technologies SA -17.67M
Alkermes Plc 1.274B
Akari Therapeutics Plc 0.00
Liquidia Corp. 144.25M